APOBEC3B and gastric cancer: In accordance with this model, studies in adrenocortical carcinoma and gastric cancer—which both show immunosuppression with APOBEC3s—have found that higher APOBEC3B expression is correlated with shorter survival (Tables 4 and 5) [37, 38, 44].